SCHEMBL19475324

SCHEMBL19475324

O=C(NC1CC1)c1cc(-c2ccccn2)nc2c(Cl)cccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 6/20 0.65
KMT2A Q03164 5/20 0.65
MEN1 O00255 4/20 0.65
POLB P06746 2/20 0.64
PPARG P37231 1/20 0.64
NR2E3 Q9Y5X4 1/20 0.64
NCOR2 Q9Y618 1/20 0.64
ALDH1A1 P00352 4/20 0.64
LMNA P02545 3/20 0.64
KDM4E B2RXH2 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
NPSR1 Q6W5P4 5/20 0.61
USP2 O75604 1/20 0.55
MAPK1 P28482 1/20 0.55
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
RAB9A P51151 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
P2RX7 Q99572 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475407 0.81 RXFP1 (0.65) RXFP1KMT2AMEN1POLBPPARG
SCHEMBL90320 0.69 RAB9A (0.88) RXFP1KMT2AMEN1POLBALDH1A1
SCHEMBL12181561 0.68 P2RX7 (0.75) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL22468544 0.68 KDM4E (0.56) KMT2AALDH1A1LMNAKDM4ESMN1; SMN2
SCHEMBL28790224 0.67 CNR2 (0.61) ALDH1A1LMNAKDM4ESMN1; SMN2
SCHEMBL2993999 0.67 KMT2A (0.57) KMT2AMEN1ALDH1A1LMNAKDM4E
SCHEMBL2241357 0.67 GRM5 (0.77) KMT2AKDM4ESMN1; SMN2
SCHEMBL4582879 0.67 P2RX7 (0.58) KMT2AMEN1POLBALDH1A1SMN1; SMN2
SCHEMBL31583752 0.66 P2RX7 (0.58) KMT2AMEN1ALDH1A1LMNAKDM4E
SCHEMBL8619739 0.66 PPARA (0.69) KMT2AMEN1POLBLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US claimed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO claimed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 RXFP1 21/4885KMT2A 3436/4885MEN1 3331/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 RXFP1 21/4885KMT2A 3436/4885MEN1 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.